SOST and type 1 diabetes mellitus: A similar reduction in bone formation was also observed in T1DM, although sclerostin levels were not different between T1DM patients and control subjects, suggesting that partially different mechanisms may be involved in the pathogenesis of skeletal fragility in T1DM and T2DM.